Indira IVF Hospital IPO Details

MAINBOARD

Indira IVF Hospital IPO DRHP (Draft Red Herring Prospectus) has been SEBI Approval Received.

The Lead Managers for Indira IVF Hospital IPO are crucial for the offering's success. They are responsible for a wide range of tasks, including preparing the company for the public market, managing the regulatory filings, and marketing the IPO to potential investors. The lead manager for this offering is Kotak Mahindra Capital Company Ltd, IIFL Capital Services Ltd, JP Morgan India Pvt Ltd, Ubs Securities India Pvt Ltd, Nomura Financial Advisory & Securities (India) Pvt Ltd. To assess their past performance and success in previous IPOs, you can view the Lead Manager Performance Summary report.

For detailed information, Refer to the Indira IVF Hospital Limited DRHP.

Indira IVF Hospital IPO Details

Open Date
-
Close Date
-
Listing Date
-
Issue Price
₹0 - ₹0
Face Value
-
Lot Size
GMP
₹0
Issue Type
IPO
Listing On
NSE, BSE
Type
Book Built Issue
Share holding pre issue
shares
Share holding post issue
shares
Total Issue Size
shares
Fresh Issue
shares
Offer for Sale
shares
DRHP Status
SEBI Approval Received

Indira IVF Hospital IPO Lot Size

ApplicationLotsSharesAmount
To be announced

Indira IVF Hospital IPO Reservation

Promoter Holding

Pre Issue:-
Post Issue:-

Documents

To be announced

Indira IVF Hospital IPO Valuations

To be announced

Indira IVF Hospital Financial Information

To be announced

About Indira IVF Hospital IPO

Indira IVF is a chain of special fertility clinics with 165+ centers and 340 IVF specialists across 20+ states in India. Its key service offerings are:

  • IVF (In Vitro Fertilization)
  • IUI (Intrauterine Insemination)
  • ICSI (Intracytoplasmic Sperm Injection)
  • Cryopreservation (freezing of eggs, sperm, and embryos)
  • Laparoscopy and hysteroscopy
  • Male infertility treatments
  • Genetic testing (PGT)

Strengths

  • Comprehensive service offerings
  • Leverage technology like Assisted Reproductive Technology treatments
  • Patient-centric services
  • Extensive network of 165 centers and over 340 IVF specialists across India

Strength Of Indira IVF Hospital IPO

To be announced

Risk Of Indira IVF Hospital IPO

To be announced

Objectives Indira IVF Hospital IPO

To be announced

Company Contact Details

Indira IVF Hospital Ltd.
4th Floor, C Tower, Times Square Buildings
Marol, Gamdevi, Andheri Kurla Road,
Andheri East, Marol Naka
Mumbai, Maharashtra, 400059
Phone: 18003092323
Email: help@indiraivf.in
Website: https://www.indiraivf.com/

Registrar Contact Details

Name: MUFG Intime India Pvt Ltd
Phone: +91-22-4918 6270
Email:

Indira IVF Hospital IPO - FAQs

The Indira IVF Hospital IPO is a MAINBOARD public issue comprising equity shares with a face value of each, aggregating to a total issue size of . The issue price has been fixed at ₹0 per equity share, and the minimum application size is shares.

The IPO opens for subscription on TBA, and closes on TBA.

MUFG Intime India Pvt Ltd has been appointed as the registrar to the issue. The equity shares are proposed to be listed on the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE).

The Indira IVF Hospital IPO opens on TBA.

Indira IVF Hospital IPO lot size is , and the minimum amount required for application is ₹.

You may apply for the Indira IVF Hospital IPO online by using either the UPI or ASBA payment method. The ASBA facility is available through the net banking platform of your respective bank. The UPI-based IPO application option is typically provided by brokers that do not offer banking services. For detailed guidance on the online IPO application process, please refer to the procedures outlined by Zerodha, Groww, Upstox, 5Paisa, Paytm Money, Fyers, Alice Blue, Nuvama, HDFC Bank, ICICI Direct, Kotak Securities, Axis Direct, and SBI Bank.

The Basis of Allotment for the Indira IVF Hospital IPO is scheduled to be finalized on TBA. Subsequently, the shares allotted will be credited to investors’ demat accounts by TBA. Investors are advised to regularly check the Indira IVF Hospital IPO allotment status for updates.

The listing date for the Indira IVF Hospital IPO has not yet been officially announced. However, the tentative listing date is scheduled for TBA.

Indira IVF Hospital IPO Grey Market Premium (GMP) refers to the unofficial price at which the company’s IPO shares are traded in the grey market prior to their listing on the stock exchange. The GMP serves as an indicator of investor demand, expected listing gains, and the overall market sentiment toward the IPO.

As of now, the current GMP stands at TBA.

Comments